Edgewise Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 590K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -590K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 42.7M | 43.6M | 37.5M | 33.6M | 36.8M | 36.4M | 32.2M | 30.7M |
| Operating Expenses | 53.5M | 56.0M | 46.9M | 42.6M | 46.0M | 45.5M | 40.4M | 38.1M |
| Operating Income | -54.1M | -56.0M | -46.9M | -42.6M | -46.0M | -45.5M | -40.4M | -38.1M |
| Other Income / Gains | 5.1M | 5.8M | 6.2M | 6.5M | 5.2M | 5.9M | 6.3M | 6.6M |
| Net Income | -49.0M | -50.2M | -40.7M | -36.1M | -40.8M | -39.7M | -34.1M | -31.5M |
| EPS (Diluted) | -0.46 | -0.47 | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 11.5M | 12.4M | 9.4M | 9.1M | 9.2M | 9.2M | 8.2M | 7.4M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 11.5M | 12.4M | 9.4M | 9.1M | 9.2M | 9.2M | 8.2M | 7.4M |
| Other Expenses | -590K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 54.1M | 56.0M | 46.9M | 42.6M | 46.0M | 45.5M | 40.4M | 38.1M |
| Interest Income | 5.1M | 5.8M | 6.2M | 6.5M | 5.2M | 5.9M | 6.3M | 6.6M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 590K | -1.6M | 523K | 567K | 554K | 629K | 602K | 534K |
| Ebitda | -53.5M | -51.9M | -40.1M | -42.0M | -45.4M | -44.9M | -39.8M | -37.6M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -49.0M | -50.2M | -40.7M | -36.1M | -40.8M | -39.7M | -34.1M | -31.5M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -0.46 | -0.47 | -0.39 | -0.34 | -0.43 | -0.42 | -0.36 | -0.34 |
| Weighted Average Shs Out | 107.1M | 102.9M | 105.5M | 104.9M | 95.1M | 92.4M | 93.8M | 93.5M |
| Weighted Average Shs Out Dil | 107.1M | 102.9M | 105.5M | 104.9M | 95.1M | 92.4M | 93.8M | 93.5M |